Rating Change
Wedbush reiterated its Outperform rating on Disc Medicine, Inc. (NASDAQ:IRON) on October 20, 2026.
reiterateNASDAQ:IRON
Wedbush Reiterates Outperform Rating on Disc Medicine, Inc. (IRON)
Wedbush reiterated its Outperform rating on Disc Medicine, Inc. (NASDAQ:IRON) on October 20, 2026.
At publication ·
What changed
Disc Medicine, Inc. (NASDAQ:IRON) · reiterate
- Firm
- Wedbush
- Rating
- Outperform to Outperform
- Price at event
- $79.33
- Market capitalization
- $3.5B
At a glance
Key takeaways
- Wedbush reiterated an Outperform rating on Disc Medicine (IRON) on October 20, 2026, with the stock trading at $79.33.
Market Context
Disc Medicine, Inc. operates in the Healthcare sector. The stock currently trades at $79.33 with a market capitalization of $3.5B. The stock has gained 6.2% over the past 52 weeks.
Analyst coverage from Wedbush provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Disc Medicine, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Disc Medicine, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | Wells Fargo | Overweight | N/A |
| Oct 20, 2026 | Wedbush | Outperform | N/A |
| Oct 19, 2026 | BMO Capital | Outperform | N/A |
| Oct 19, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Sep 16, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View IRON Stock Page
Frequently Asked Questions
What does the Outperform rating mean for IRON?
A rating of Outperform from Wedbush reflects the analyst's outlook on Disc Medicine, Inc. (NASDAQ:IRON). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the IRON forecast page.